✳flâneur — a map of the web's best reading

Sam Altman invested $180 million into a company trying to delay death | MIT Technology Review

technologyreview.com · 3,188 words · saved by 1 readers

Can anti-aging breakthroughs add 10 healthy years to the human lifespan? The CEO of OpenAI is paying to find out.

Sam Altman invested $180 million into a company trying to delay death | MIT Technology Review Skip to Content When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to the average human life span . It had set up its headquarters in a raw warehouse space near San Francisco just the year before, bolting shipping containers to the concrete floor to quickly make lab space for the scientists who had been enticed to join the company. Retro said that it would “prize speed” and “tighten f

Explore this link on the map →

related reading